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Abstract.  Osteopontin (OP) or bone sialoprotein is a 
recently characterized extracellular matrix protein 
which is abundant in bone and is produced by osteo- 
blasts.  Parathyroid hormone (PTH) is a potent cal- 
citropic hormone which regulates osteoblastic function 
including the synthesis of extracellular matrix proteins. 
This study examines the effect of human PTH (hPTH- 
[1-34])  on the expression of this novel protein in rat 
osteoblast-like cells, hPTH(1-34)  significantly de- 
creased the amount of OP in culture media of the rat 
osteoblastic osteosarcoma cell line, ROS  17/2.8,  de- 
tected by Western immunoblot analysis, hPTH(1-34) 
also suppressed the steady-state level of OP mRNA 
two- to threefold with an EDso of ~  3  x  10  -'° M.  This 
inhibition was detectable at 24 h,  reached its nadir at 
48 h, and lasted at least up to 96 h.  The hPTH(1-34) 
effects were mimicked by isobutylmethylxanthine, 
cholera toxin, 8-bromo-cAMP,  forskolin, and isopro- 
terenol, hPTH(I-34)  suppressed by two- to threefold 
the rate of OP gene transcription, estimated by nuclear 
run-on assays. The suppression of OP mRNA levels 
by hPTH(1-34)  was also seen when basal levels were 
increased by transforming growth factor type/3, or 
1,25-dihydroxyvitamin D3,  or were decreased by dexa- 
methasone. A  similar decrease in the steady-state level 
of OP mRNA by hPTH(1-34)  was also observed in 
primary cultures of osteoblast-enriched cells from fetal 
rat calvaria. These findings indicate that hPTH(1-34) 
suppresses the production of the novel extracellular 
matrix protein, OP,  in osteoblasts at least in part 
through transcriptional control. 
STEOPONTIN (OP)' is a 44-kD glycoprotein which is 
rich in aspartic acid and glutamic acid and contains 
one phosphoserine and  12  phosphothreonine resi- 
dues  (Prince  et  al.,  1987).  OP  is  an  abundant  noncol- 
lagenous protein in bone (Franzen and Heinegard, 1985) and 
was immunohistochemically detected in bone matrix,  os- 
teoid, osteoblasts, osteocytes, preosteoblast-like cells, neu- 
rons, neurosensory cells, and the proximal convoluted tubules 
of the kidney (Mark et al.,  1987a,b,  1988).  OP messenger 
RNA was found in bone and kidney and at much lower levels 
in brain and lung (Yoon et al., 1987).  In embryonic rat cal- 
varia, OP mRNA expression was shown to increase between 
15 and 21  d of gestation during development (Yoon et al., 
1987).  The amino acid sequence of OP predicted from a 
cDNA cloned from a rat osteosarcoma (ROS  17/2.8) cell li- 
brary (Oldberg et al., 1986) was shown to be >92 % identical 
to that of2ar (Nomura et al., 1988). The 2ar gene was origi- 
nally isolated on the basis of its enhanced expression in the 
mouse JB4 epidermal cell line in response to  12-O-tetra- 
decanoyl-phorbol-13-acetate  (TPA)  (Smith  and  Denhardt, 
1987).  Since 2ar appears to be the product of a single copy 
1. Abbreviations used in this paper:  hPTH(1-34), human parathyroid hor- 
mone (1-34); OP, osteopontin; PTH, parathyroid hormone; TGF-/3, trans- 
forming growth factor type 8; TPA, 12-O-tetradecanoyl-phorbol-13-acetate. 
gene, it is probably the mouse homologue of rat OP (Nomura 
et al., 1988).  In fact, 2ar mRNA, similar to rat OP, was ex- 
pressed in mouse calvaria, vertebrae, and kidney (Nomura 
et al., 1988). In addition, 2ar mRNA was also expressed in 
placenta and decidua (Nomura et al., 1988).  Although OP/ 
2ar mRNA was expressed in cultured fibroblasts in response 
to TPA, neither the mRNA nor the antigen was detected in 
situ in rat or mouse skin (Mark et al.,  1987b,  1988;  Yoon 
et al.,  1987; Nomura et al.,  1988). 
The cDNA-predicted amino acid sequence of OP contains 
the Arg-Gly-Asp-Ser(RGDS) motif (Oldberg et al.,  1986), 
which is found in fibronectin and other cell-adhesion pro- 
teins, and was shown to interact with cell surface receptors 
(Pytela et al., 1986; Tamkun et al., 1986). OP also has high 
affinity to hydroxyapatite, possibly due to its nine consecu- 
tive aspartic acid residues (Oldberg et al.,  1986;  Prince et 
al., 1987). Based on these features, OP was proposed to par- 
ticipate in cell attachment to mineralized matrix (Oldberg et 
al.,  1986).  Indeed, OP promoted the attachment of rat os- 
teosarcoma cells and human gingiva fibroblasts to plastic 
dishes, and this effect was inhibited by RGD-containing pep- 
tides (Oldberg et al.,  1986;  Somerman et al.,  1987).  The 
physiological function of OP is not yet known. The temporal 
and tissue-specific OP/2ar expression seen in vivo (Yoon et 
al., 1987; Nomura et al., 1988) indicates that this protein is 
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suggests  a functional role in these tissues. 
The steady-state level of OP mRNA or OP in osteoblast- 
like cells is increased by 1,25-dihydroxyvitamin I)3 (Yoon et 
al.,  1987; Prince  and  Butler,  1987) and  is  reduced  by 
glucocorticoids (Yoon et al., 1987). 2ar mRNA in epidermal 
cells and fibroblasts is induced by embryonic carcinoma- 
derived  growth  factor and basic  fibroblast growth  factor 
(Nomura et al.,  1988) in addition to TPA (Smith and Den- 
hardt,  1987).  We  have  recently  shown that transforming 
growth factor type fl (TGF-/5) enhances OP gene expression 
through transcriptional control in the rat osteoblast-like os- 
teosarcoma cells, ROS  17/2.8, and in newborn mouse cal- 
varia-derived osteoblast-like cells, MC3T3E1  (Noda et al., 
1988a).  These observations suggest that OP/2ar expression 
is regulated by factors which control growth and/or differen- 
tiation. 
Parathyroid hormone (PTH) has pronounced effects on the 
production of many extracellular matrix proteins in osteo- 
blastic cells (Luben et al.,  1976; Wong et al., 1977; Kream 
et al.,  1980, 1986; Majeska and Rodan, 1982;  Hamilton et 
al., 1985; Noda et al., 1988b). Moreover, target cells of PTH 
correspond to OP-producing cells which include proximal 
tubule,  distal  tubule,  and  ascending  loop  of Henle  cells 
(Klahr and Hruska, 1984), in addition to osteoblasts (Rodan 
and Rodan,  1984).  This study examined the effects of PTH 
on OP gene expression in the osteoblastic osteosarcoma ROS 
17/2.8 cells and in primary cultures of fetal rat calvaria cells. 
We found that PTH inhibited OP gene expression at least in 
part through transcriptional control. 
Materials and Methods 
Human PTH (1-34) (hPTH[1-34]) was purchased from Bachem Biochemi- 
cal (Torrance,  CA). Porcine TGF-BI was obtained from R&D Systems, Inc. 
(Minneapolis, MN).  1,25-dihydroxyvitamin D3 was a kind gift from Dr. 
Uskokovic at  Hoffman-LaRoche (Nutley,  N  J).  Forskolin was purchased 
from Calbiochem-Behring Corp. (La Jolla, CA). Cholera toxin, isobutyl- 
methylxanthine,  (-)isoproterenol,  and  8-bromo-cAMP were  purchased 
from Sigma Chemical Co. (St. Louis, MO). Proteinase K and vanadyl ribo- 
nucleoside complex were obtained from Bethesda Research Laboratories 
(Gaithersburg, MD). 
Cell Culture 
ROS 17/2.8 cells were grown in 9.5-,  150-, or 500-cm  2 Costar (Cambridge, 
MA) or Nunc (Roskilde, Denmark) tissue culture dishes in modified Ham's 
Fl2 medium containing 5% FBS as described previously (Majeska et al., 
1985; Noda and Rodan, 1987).  Fetal rat osteoblast-enriched cells (fraction 
3, F3 cells) were isolated by sequential enzymatic digestion of 19 d calvaria 
and were grown in modified Ham's Fl2 media supplemented with 2% FBS 
and 5% horse serum as described previously (Wong and Cohn, 1974; Noda 
et al.,  1987a).  To examine the effects of PTH and other agents, the media 
were replaced every 24 h unless described otherwise. 
Western lmmunoblot Analysis 
ROS 17/2.8 cells were grown to confluence in media containing 5% FBS. 
The cultures were then rinsed three times with PBS and were cultured in 
serum-free modified F12 media containing 0.1% vol/vol vehicle (0.1% acetic 
acid, 0.1% bovine serum albumin) or 10  -7 M hPTH(I-34) for 96 h. Then 
the media were collected and the cells were trypsinized and counted by a 
Coulter counter (Coulter Electronics, Inc., Hialeah, FL). The media were 
centrifuged at  12,000 g  for 10 rain at 4°C to remove cell debris, and the 
supernatants were concentrated 2zl-fold by Centricon-lO (Amicon Corp., 
Danvers, MA) at 4°C according to the manufacturer's instructions. Aliquots 
corresponding to equal numbers of cells were incubated with 5 %/3-mercap- 
toethanol in the electrophoresis buffer and were analyzed by  10%  SDS- 
PAGE (Laemmli, 1970).  The proteins were electrophoretically transferred 
to nitrocellulose filters as described previously (Brunette, 1981). The an- 
tisera against rat osteopontin were described elsewhere (Mark et al., 1987b) 
and were kindly provided by Drs. C. W. Prince (University of Alabama, 
Birmingham, AL) and W. T. Butler (University of Texas Health Sciences 
Center,  Houston, TX).  The filters were incubated with the antisera and 
anti-rabbit  lgG  goat  antibody  conjugated  with  horseradish  peroxidase 
(Bethesda Research Laboratories) followed by incubation with 4-chloro-1- 
naphtol  for color development according to the manufacturer's protocol 
(Bethesda Research Laboratories). 
RNA Isolation 
ROS  17/2.8 cells or fetal  calvaria-derived osteoblast-enriched (F3) cells 
were grown to confluence in 150- or 500-cm  2 dishes and were treated for 
indicated periods of time with hPTH(1-34) or other agents. Cytoplasmic 
RNA was extracted as described previously (Greenberg and Ziff,  1984; 
Noda and Rodan,  1987).  Cells (2-6  ×  107) were rinsed with cold PBS, 
scraped in PBS, and centrifuged at 500 g  at 4°C.  The cell pellets were 
resuspended in  1 ml of NP-40 lysis buffer (10 mM Tris-HCl. pH 7.4,  10 
mM NaCl,  3  mM MgCI2,  0.5%  vol/vol NP-40),  incubated on ice for 5 
rain, and then spun at 500 g at 4°C for 5 min. The supernatants were mixed 
with vanadyl ribonucleoside complex (final  concentration  10 mM),  vor- 
texed, and spun at 12,000 g at 4°C for 10 rain. The supernatants were mixed 
with equal volume of digestion buffer (0.2  M Tris-HCl, pH 7.4,  0.44 M 
NaC1, 2 % SDS, 25 mM EDTA) containing proteinase K (final concentration 
200 #g/ml) and were incubated at 37°C for 60 rain, followed  by phenol/chlo- 
roform (1:1) extraction, and ethanol precipitation. 
Northern Blot Analysis 
Total  RNA  (10 or 20 #g)  was subjected to electrophoresis through  1% 
agarose-formaldehyde (0.44 M) gel and electrophoretically transferred to 
nylon  filters  (Hybond  N;  Amersham  Corp.,  Arlington  Heights,  IL) 
(Thomas,  1980).  Complementary DNA probes for rat osteopontin and rat 
~-tubulin were kindly provided by Drs. K. Yoon (Merck, Sharp, and Dohme 
Research  Laboratories,  West Point,  PA)  (Yoon  et  al.,  1987)  and  S. R. 
Farmer (Boston University, Boston, MA) (Bond et al., 1984),  respectively. 
Rat  alkaline phosphatase cDNA was described previously (Noda et al., 
1987b).  Rat  actin cDNA was purchased from Stanford University (Palo 
Alto, CA). 
The  insert of each eDNA plasmid was purified and labeled with [c~- 
32P]dCTP(3,000  Ci/mmol, Amersham Corp.) by using random oligonucle- 
otide primers (Amersham Corp.) and Klenow fragments as described by 
Feinberg and Vogelstein (1984) to a specific activity >10  s cpm/#g. Mem- 
branes with bound RNA were irradiated for 2  min by ultraviolet light to 
cross-link the RNA to the filters.  Then the filters were prehybridized over- 
night at 42°C in 50% formamide, 5x SSC (Ix SSC =  0.15 M NaCI/15 mM 
Sodium citrate), 5 x  Denhardt's solution, and 200 #g/ml sonicated herring 
sperm DNA. Hybridization was carried out for 16-24 h in fresh prehybrid- 
ization buffer to which each 32P-labeled probe was added at  106 cpm/ml. 
Filters were washed three times in 2×  SSC, 0.1% SDS at room temperature 
for 5 rain each; and once in 0.Ix SSC, 0.1% SDS at 65°C; and were exposed 
to  x-ray  films (Eastman  Kodak  Co.,  Rochester,  NY)  with  intensifying 
screens, 
In Vitro Transcription (Nuclear Run-on) Assay 
Isolation of nuclei, in vitro transcription, and hybridization were carried out 
essentially as described previously (McKnight and Palmiter,  1979;  Grou- 
dine et al.,  1981) with minor modifications. Nuclei (2-3  x  t07) were iso- 
lated by gentle homogenization of cells on ice in a buffer containing l0 mM 
KCI, 10 mM Tris-HCl, pH 7.4,  1.5 mM MgC12, 0.25% vol/vol NP-40. The 
isolated nuclei were incubated at 25°C for 20 rain in a buffer containing 50 
mM Tris-HCl, pH 7.4,  100 mM ammonium sulfate, 1.8 mM dithiothreitol, 
1.8 mM MnCI2, 80 U RNasin, 0.3 mM each ATE GTE and CTE and 100 
#Ci of [u-32p]UTP (800 Ci/mmol, Amersham Corp.) followed by sequen- 
tial  digestions with  DNase I  and proteinase K.  RNA  was extracted by 
phenol/chloroform and  was ethanol precipitated.  After centrifugation at 
12,000 g for l0 min, the pellets were dissolved in 6 M guanidium hydro- 
chloride followed by addition ofO.5 vol ethanol, and were reprecipitated at 
-20°C overnight. After centrifugation at 12,000 g for 10 min at 4°C, the 
pellets were rinsed with cold 80% ethanol, dried, and resuspended in TE 
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production  in  culture  media  of  ROS 
17/2.8 cells. Confluent cells in 150-cm  2 
dishes were treated with 10  -7 M hPTH- 
(1-34)  for 96  h  in  serum-free  media. 
Media were concentrated by Centricon- 
10 and aliquots were examined by West- 
ern  immunoblot  analysis  as  described 
in  Materials  and  Methods.  Molecular 
masses in kilodaltons and the position of 
OP are indicated.  C, control;  P,  PTH- 
treated  culture.  The  figure  represents 
one of two similar experiments. 
buffer (10 mM Tris-HCl, pH 7.4,  1 mM EDTA). Isolated 32p-labeled tran- 
scripts (final concentration 2  x  106 cpm/ml) were hybridized to plasmids 
(2 #g each) bound to nitrocellulose filter.  Prehybridization (12-16  h) and 
hybridization (72 h) were carded out in 5 ×  SSC, 50 % formamide, 5 ×  Den- 
hardt's solution, 10 mM EDTA, 100 mM Tris-HCl, pH 7.4, 20 #g/ml tRNA, 
10 #g/mi polyadenylic acid, 10/~g/ml sonicated herring sperm DNA, and 
0.1% SDS at 42°C. Filters were washed three times in 2×  SSC, 0.1% SDS 
at room temperature for 5 min each and once in 0.1x  SSC, 0.1%  SDS at 
60°C for 20 min. The filters were then autoradiographed at  -70°C using 
intensifying screens. Quantitation of the signals was carried out by densito- 
metric scanning. 
Results 
The treatment of cells with  10  -7  M  hPTH(1-34)  for 96  h 
greatly reduced  OP  levels in  culture  media,  estimated by 
Western immunoblot analysis (Fig.  1). The specificity of the 
immunoblot analysis with the same antisera has previously 
been demonstrated (Noda et al.,  1988a). Mobility of OP on 
SDS-PAGE was reported to depend on acrylamide concen- 
tration (45 kD in  15%  and 75 kD in 5-15%  gradient gels) 
(Prince et al.,  1987). In 10% gels, OP migrated as a 60-kD 
band (Fig.  1). 
hPTH(1-34) treatment also decreased the steady-state level 
of  OP  mRNA.  This  effect  was  dose-dependent  between 
10-"  M  and  10  -8 M,  which  reduced OP mRNA levels by 
about threefold.  The  half-maximal effect dose (EDso)  was 
'~,3  x  10  -'0 M (Fig. 2, A and B). Actin mRNA on the same 
filter was used as control (Fig.  2  C).  The reduction of the 
steady-state level of OP  mRNA produced  by hPTH(1-34) 
was first detected at 24 h, reached its nadir at 48 h, and re- 
mained at that level at least up to 96 h  (Fig.  3). 
PTH stimulates adenylate cyclase in both osteoblast-like 
osteosarcoma (ROS  17/2.8)  cells  and  primary cultures  of 
osteoblast-enriched  fetal  rat  calvaria  cells  (Majeska  and 
Rodan,  1982; Rodan and Rodan,  1984). To test whether the 
PTH effect on OP mRNA was related to cAMP, ROS 17/2.8 
cells were treated with  1 mM isobutylmethylxanthine,  0.3 
#g/ml cholera toxin, 0.5 mM 8-bromo-cAMP, 10 #M forsko- 
lin, or 1 #M (-)isoproterenol. Treatment with each of these 
agents for 48 h reduced the steady-state level of OP mRNA 
at least as much as  10  -7 M  hPTH(1-34) (Fig. 4).  Isobutyl- 
methylxanthine was the most potent inhibitor in this series. 
Alkaline phosphatase mRNA level was also reduced by these 
agents. ~Tubulin mRNA, used as control, was unchanged. 
To study the mechanism for PTH regulation of OP mRNA, 
we examined the effect of 10  -7 M  hPTH(1-34) on the tran- 
scriptional rate of the OP gene by in vitro nuclear transcrip- 
Figure 2. PTH suppression of the steady-state levels of OP mRNA. 
Confluent ROS 17/2.8 cells were treated with hPTH(1-34) at the in- 
dicated concentrations for 72 h. Northern blot analysis was carried 
out as described  in Materials  and Methods.  The positions of OP 
(A), B-actin(AC) (C), 28-S and 18-S ribosomal RNA (A and C) are 
indicated. (A) Dose dependence of  PTH effects on OP mRNA level. 
(B) Quantitation ofOP mRNA bands in A. (C) B-actin mRNA lev- 
els on the  same  filter. The figures represent  one of two similar 
experiments. 
tion  (run-on)  assays and  found  it to be reduced  by about 
threefold  (Fig.  5).  In the  same experiment,  the  transcrip- 
tional rate of the/3-actin gene, which served as the control, 
was not affected by hPTH(1-34) (Fig. 5). Treatment with 0.3 
#g/ml cholera toxin also showed a similar suppression in the 
rate of OP gene transcription (data not shown). 
Other factors which modulate OP gene expression include 
TGF-/3 which enhances the expression at least in part through 
transcriptional regulation (Noda et al.,  1988a), dexametha- 
sone which decreases OP mRNA levels, and 1,25-dihydroxy- 
vitamin D3  which  also  increases  OP  mRNA levels (Yoon 
et al.,  1987). The combined effects of hPTH(1-34) and each 
of these agents on OP mRNA accumulation are shown in 
Fig. 6. When the cells were treated with saturation doses of 
Noda and Rodan PTH Regulation of Osteopontin Gene Expression  715 Figure 3. Time course of PTH effects on the steady-state levels of 
the OP mRNA. Confluent  ROS 17/2.8 cells were cultured for the 
indicated periods of time (hours) in the absence (C) or the presence 
(P) of 10  -7 M hPTH(1-34).  Northern blot analysis  of total RNA 
was carried out as described in Materials  and Methods.  The posi- 
tions of OP and  18-S ribosomal RNA are indicated.  The figure 
represents  one of two similar experiments. 
hPTH(1-34) (10  -7 M) and TGF-~ (4 ng/ml), the steady-state 
OP mRNA levels were similar to control.  Together with a 
saturation  dose  of dexamethasone  (10  -7  M),  hPTH(1-34) 
(10  -7 M)  caused  further  suppression  of OP mRNA levels. 
1,25-dihydroxyvitamin  D3  (10  -8  M)  increased  OP  mRNA 
about tenfold and hPTH(1-34)  (10  -7 M) partially  inhibited 
this  increase.  As  previously  reported  (Noda  and  Rodan, 
1987),  alkaline phosphatase mRNA level was increased by 
TGF-/~ and hPTH(1-34)  also suppressed  this effect. 
PTH effect on osteopontin mRNA in os'teoblast-like ceils 
was also tested in osteoblast-enriched primary cultures of fe- 
tal rat calvaria-derived (F3) cells. Fig. 7 shows that the effect 
of hPTH(1-34)  (10  -7  M)  on OP  mRNA levels  in  fetal  rat 
calvaria (F3) cells was similar to that on ROS  17/2.8 cells, 
indicating that PTH has this effect not only in osteoblastic 
osteosarcoma cells but also in nontransformed osteoblastic 
cells. 
Figure 5. PTH suppression  of OP gene 
transcription.  Confluent  ROS  17/2.8 
cells were cultured for 36 h in the pres- 
ence (P) or the absence (C) of l0  -7 M 
hPTH(1-34)  and  an  in vitro  nuclear 
transcription  (run-on)  assay  was  car- 
ried out as described in Materials  and 
Methods.  The figure represents  one of 
three similar  experiments.  AC,  /~-ac- 
tin; pBS, plasmid vector (Bluescribe). 
Discussion 
The reduction in the rate of OP gene transcription by PTH 
indicates that PTH regulates OP expression at least in part 
via transcriptional control. The degree of the PTHeffects on 
the steady-state levels of OP mRNA was similar to that on 
the rate of OP gene transcription.  Preliminary studies also 
indicated that PTH had no significant effect on OP mRNA 
stability (data not shown). Taken together, these results sug- 
gest that transcriptional control is possibly the major regula- 
tory pathway for PTH action on OP gene expression.  PTH 
stimulates  cAMP accumulation in ROS  17/2.8 cells,  osteo- 
blast-enriched fetal rat calvaria cells,  and most target cells. 
The effects of cAMP-elevating agents and cAMP analogue on 
OP mRNA were very similar to those of PTH, suggesting the 
possible involvement of cAMP in this PTH action on OP ex- 
pression,  cAMP mediation has previously been implicated 
in the transcriptional control of genes encoding human pro- 
encephalin, human prolactin, corticotropin-releasing factor, 
and somatostatin (Cooke et al., 1981; Shibahara et al.,  1983; 
Shen and Rutter, 1984; Comb et al., 1986). These genes con- 
tain  short  homologous cis-regulatory  elements  in  their  5' 
flanking regions, the deletion of which abolishes modulation 
by cAMP (Comb et al.,  1986). The data presented here sug- 
gest the presence of cAMP-responsive negative control ele- 
ment(s) in the regulatory region of the OP gene. cis-Regula- 
tory  elements  which  share  the  structure  of the  consensus 
sequence  have  been  shown  to  mediate  both  positive  and 
negative  effects  of glucocorticoid.  The pathway(s)  leading 
Figure 4. Effects of cAMP analog and agents which stimulate ade- 
nylate cyclase on OP mRNA accumulation. Confluent  ROS 17/2.8 
ceils were treated  for 48 h with 10  -7 M hPTH(1-34) (it'),  10  -3 M 
isobutylmethylxanthine  (IB), 0.3 ttg/ml  cholera toxin  (CT), 5  × 
10  -~ M  8-bromo-cAMP (8B), 5  x  10  -5 M  forskolin  (FR), and 
10  -6 M  isoproterenol  (IS).  Northern blot analysis  of total  RNA 
was carded out as described in Materials  and Methods.  Positions 
of OP, alkaline phosphatase (AP), ~-tubulin  (TB), and the 28-S and 
18-S ribosomal RNA are indicated.  The figure represents  one of 
two similar  experiments. 
Figure 6.  Modulation by hPTH(1-34) (10  -7 M) of TGF-/$1 (4 ng/ 
ml), dexamethasone  (DEX) (10  -7 M), and  1,25-dihydroxyvitamin 
D3(10  -8 M); effects on the steady-state  levels of OP mRNA. Con- 
fluent  ROS  17/2.8 ceils  were treated  for 48 h with combinations 
of hPTH(I-34) and other agents as shown in the figure.  -  and  + 
indicate the absence and the presence of hPTH(1-34), respectively. 
Northern blot analysis was carried out as described in Materials and 
Methods.  The figure  represents  one of two similar experiments. 
The positions  of OP alkaline phosphatase (AP), and the 28-S and 
18-S ribosomal RNA are indicated. 
The Journal of Cell Biology, Volume 108, 1989  716 Figure 7. PTH suppression of 
the  steady-state level of OP 
mRNA in  fetal  rat  calvaria 
cells.  Cells  were  prepared 
from  19 d fetus as described 
in  Materials  and  Methods. 
Confluent cells were cultured 
for48 h in the presence (P) or 
the  absence  (C)  of  10  -7  M 
hPTH(1-34).  Northern  blot 
analysis was carried out as de- 
scribed in Materials and Meth- 
ods. The figure represents one 
of two  similar  experiments. 
The position of OE  and the 
28-S and 18-S ribosomal RNA 
are indicated. 
from cAMP elevation to gene regulation have not been eluci- 
dated. The cis-regulatory elements presumably interact with 
proteinaceous factors (Maniatis et al., 1987) which could be 
modulated by protein kinase A phosphorylation. A  similar 
scheme was proposed for the regulation of collagenase gene 
promoter by TPA via protein kinase C  phosphorylation of 
AP-1 (Angel et al.,  1987). 
In various cell types OP/2ar mRNA expression is stimu- 
lated by several other agents which modulate cell growth, in- 
cluding steroid hormone (Yoon et al., 1987; Prince and But- 
ler, 1987) and peptide growth factors (Smith and Denhardt, 
1987; Nomura et al., 1988; Noda et al., 1988a). The inhibi- 
tion of OP expression by PTH in osteoblastic cells is proba- 
bly not related to modulation of  proliferation but rather to the 
effect of this hormone on phenotype-related proteins in these 
cells. 
Inhibition of OP gene expression in osteoblast-like cells by 
PTH is consistent with the known catabolic effects of this 
hormone, which include inhibition of collagen (Luben et al., 
1976; Kream et al., 1980,  1986) and of alkaline phosphatase 
(Luben et al., 1976; Wong et al., 1977; Majeska and Rodan, 
1982)  synthesis.  The  similar  response  of  OP  to  PTH 
strengthens the relationship of this novel protein to the os- 
teoblastic phenotype. Certain osteoblastic products such as 
plasminogen  activator  (Hamilton  et  al.,  1985)  and  col- 
lagenase (Sakamoto and Sakamoto,  1986) are increased by 
PTH.  However,  these  proteins  may  be  involved in  bone 
resorption and may participate in the catabolic effects of this 
hormone (Luben et al.,  1976; Wong et al.,  1977;  Kream et 
al.,  1980,  1986;  Majeska and Rodan,  1982).  In contrast, 
TGF-/3, a possible anabolic agent on bone, enhances the ex- 
pression of collagen (Centrella et al.,  1987;  Canalis et al., 
1988), alkaline phosphatase (Harrod et al., 1985; Noda and 
Rodan,  1987;  Pfeilshifter et  al.,  1987),  and  osteopontin 
(Noda et al., 1988a) in osteoblastic cells, thus having oppo- 
site effects to those of PTH. The TGF-/3 effects are probably 
not mediated by cAMP (Insogna et al., 1987). Further study 
will be necessary to elucidate the molecular details of these 
regulatory pathways. 
Extrapolation of these findings to the in vivo situation re- 
mains  to  be  established.  The  expression of OP  and  OP 
mRNA have been consistently observed in osteoblasts and 
bones in vivo in both rat (Yoon  et al.,  1987;  Mark et al., 
1987a,b, 1988) and mouse (Nomura et al., 1988). This study 
suggests that OP expression would be reduced by PTH as 
part of its catabolic effects on bone. 
We are indebted to Drs. William T. Butler and Charles W. Prince for the 
use of rat osteopontin and antisera. We are also grateful to Drs. Kyonggeun 
Yoon and Stephen R. Farmer fbr the rat osteopontin and the tubulin cDNA 
clones, Drs. John Harrison and Barbara Kream for their advice regarding 
the nuclear run-on assay, and to Ms. Dianne McDonald and Jeannie Arizin 
for their help in preparing this manuscript. 
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